Literature DB >> 23381826

Effect of hyperbaric oxygen therapy on liver function during intermittent ischemia.

Leticia Botigeli Baldim1, Ricardo Nejo, Maria Eliza Jordani Souza, Maria Cecília Jordani Gomes, Maria Aparecida Neves Cardoso Picinato, Clarice Fleury Fina, Orlando Castro-e-Silva.   

Abstract

PURPOSE: To analyze the effects of hyperbaric oxygen therapy on liver function in rats previously subjected to ischemia and reperfusion.
METHODS: A randomly distribution of 23 Wistar rats was conducted into three groups: SHAM, animals subjected to surgical stress without restricting blood flow by clamping the hepatic pedicle, IR, rats underwent hepatic vascular occlusion intermittently for two complete cycles of 15 minutes of ischemia followed by 5 min of reperfusion, IR / HBO, rats underwent hepatic pedicle clamping and thereafter exposed to hyperbaric oxygen pressure of 2 absolute atmospheres for 60 minutes. We evaluated liver function through mitochondrial function, determined by the stages 3 and 4 of respiration, respiratory control ratio (RCR) and mitochondrial permeability transition (Swelling). Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were also quantified . We analyzed the results using the Mann-Whitney test and were considered significant all results with p <0.05.
RESULTS: There were significant differences between the results of stage 3 in SHAM vs IR group ; of the stage 4 in the groups IR vs SHAM and SHAM vs IR /HBO; of the Respiratory Control Ratio (RCR) in the group IR vs IR / HBO ; of alanine aminotransferase in the groups IR vs SHAM , SHAM vs IR/HBO and IR vs IR / HBO; aspartate aminotransferase in the groups SHAM vs IR and SHAM vs IR / HBO.
CONCLUSION: The whole analysis of the mitochondrial function indicators permits us to conclude that the hyperbaric oxygen therapy acted as a protective agent of the mitochondrial function, minimizing the ischemia-reperfusion injury of the hepatic parenchyma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23381826     DOI: 10.1590/s0102-86502013001300012

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  4 in total

1.  Early hyperbaric oxygen therapy improves survival in a model of severe sepsis.

Authors:  Jonathan L Halbach; James M Prieto; Andrew W Wang; Dennis Hawisher; David M Cauvi; Tony Reyes; Jonathan Okerblom; Israel Ramirez-Sanchez; Francisco Villarreal; Hemal H Patel; Stephen W Bickler; George A Perdrizet; Antonio De Maio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-15       Impact factor: 3.619

2.  An ex vivo model for studying hepatic schistosomiasis and the effect of released protein from dying eggs.

Authors:  Geoffrey N Gobert; Sujeevi K Nawaratna; Marina Harvie; Grant A Ramm; Donald P McManus
Journal:  PLoS Negl Trop Dis       Date:  2015-05-12

Review 3.  Application of hyperbaric oxygen in liver transplantation.

Authors:  Hu Lv; Cui-Hong Han; Xue-Jun Sun; Wen-Wu Liu
Journal:  Med Gas Res       Date:  2016-12-30

Review 4.  Hyperbaric Oxygen Treatment: Effects on Mitochondrial Function and Oxidative Stress.

Authors:  Nofar Schottlender; Irit Gottfried; Uri Ashery
Journal:  Biomolecules       Date:  2021-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.